Pharmacokinetics of (glycolato-0,0?)-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin-Reference-Cited by-同舟云学术

Pharmacokinetics of (glycolato-0,0?)-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin

Published:1989 Issue:4 Volume:23 Page:243-246
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother. Pharmacol.

Author:

Sasaki Yasutsuna,Tamura Tomohide,Eguchi Kenji,Shinkai Tetsu,Fujiwara Yasuhiro,Fukuda Masaaki,Ohe Yuichiro,Bungo Masami,Horichi Naoya,Niimi Shigeki,Minato Koichi,Nakagawa Kazuhiko

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00451649.pdf

Reference20 articles.

1. Einhorn LH (1981) Testicular cancer as a model of a curable neoplasma. The Richard and Hinda Rothenthal Foundation Award Lecture. Cancer Res 41:3275

2. Einhorn LH, Donohue J (1977) cis-Diamminedichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293

3. Gralla RJ (1981) Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: a randomized trial investigating two dosage schedules. Ann Intern Med 95:414

4. Harrap KR, Jones M, Wilkinson CR, Clink HMcD, Sparrow S, Mitchley BCV, Clarke SA, Veasy A (1980) Antitumor, toxic and biochemical properties of cisplatin and eight other platinum complexes. In: Prestayko AW, Cooke ST, Carter SK (eds) Cisplatin. Current status and new developments. Academic Press, New York, p 193

5. Higby DJ, Wallance HJ Jr, Albert DJ, Holland JF (1977) Diamminedichloroplatinum: a phase I study showing response in testicular and other tumors. Cancer 33:1219

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022;International Journal of Clinical Oncology;2023-07-16

2. Poor Renal Function and a High Modified Glasgow Prognostic Score Are Predictive Factors for Nedaplatin/5-Fluorouracil Combination Therapy-induced Febrile Neutropenia;Anticancer Research;2023-04-25

3. Metallodrug binding to serum albumin: Lessons from biophysical and structural studies;Coordination Chemistry Reviews;2023-04

4. Comparative assessment of clinical trials, indications, pharmacokinetic parameters and side effects of approved platinum drugs;Pharmacia;2022-01-05

5. Establishment of nedaplatin safety dose formula based on renal function for combination chemotherapy with nedaplatin and 5-fluorouracil in patients with esophageal cancer;International Journal of Clinical Oncology;2021-10-22